Clinical Trial Update: A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label Extension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of elamipretide for Primary Mitochondrial Myopathy terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Myopathy

Drugs mentioned

• Elamipretide (elamipretide)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Primary Mitochondrial Myopathy | Phase 3 | Status: TERMINATED | Results posted: 2021-04-02